Disparities in Hepatocellular Carcinoma Incidence, Stage, and Survival: A Large Population-Based Study
Open Access
- 18 March 2021
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 30 (6) , 1193-1199
Abstract
Background: Liver cancer is one of the most rapidly increasing cancers in the United States, and hepatocellular carcinoma (HCC) is its most common form. Disease burden and risk factors differ by sex and race/ethnicity, but a comprehensive analysis of disparities by socioeconomic status (SES) is lacking. We examined the relative impact of race/ethnicity, sex, and SES on HCC incidence, stage, and survival. Methods: We used Surveillance, Epidemiology, and End Results (SEER) 18 data to identify histologically confirmed cases of HCC diagnosed between January 1, 2000 and December 31, 2015. We calculated age-adjusted HCC incidence, stage at diagnosis (local, regional, distant, unstaged), and 5-year survival, by race/ethnicity, SES and sex, using SEER*Stat version 8.3.5. Results: We identified 45,789 cases of HCC. Incidence was highest among low-SES Asian/Pacific Islanders (API; 12.1) and lowest in high-SES Whites (3.2). Incidence was significantly higher among those with low-SES compared with high-SES for each racial/ethnic group (P < 0.001), except American Indian/Alaska Natives (AI/AN). High-SES API had the highest percentage of HCC diagnosed at the local stage. Of all race/ethnicities, Blacks had the highest proportion of distant stage disease in the low- and high-SES groups. Survival was greater in all high-SES racial/ethnic groups compared with low-SES (P < 0.001), except among AI/ANs. Black, low-SES males had the lowest 5-year survival. Conclusions: With few exceptions, HCC incidence, distant stage at diagnosis, and poor survival were highest among the low-SES groups for all race/ethnicities in this national sample. Impact: HCC prevention and control efforts should target low SES populations, in addition to specific racial/ethnic groups.Keywords
Funding Information
- NIH NCI (P30CA16042)
- NIH NCI (K07CA197179)
This publication has 24 references indexed in Scilit:
- Changing Hepatocellular Carcinoma Incidence and Liver Cancer Mortality Rates in the United StatesAmerican Journal of Gastroenterology, 2014
- Using a composite index of socioeconomic status to investigate health disparities while protecting the confidentiality of cancer registry dataCancer Causes & Control, 2013
- Socioeconomic Status and Hepatocellular Carcinoma in the United StatesCancer Epidemiology, Biomarkers & Prevention, 2012
- Hepatocellular Carcinoma Confirmation, Treatment, and Survival in Surveillance, Epidemiology, and End Results Registries, 1992-2008Hepatology, 2011
- Race, gender, class, and sexual orientation: intersecting axes of inequality and self-rated health in CanadaInternational Journal for Equity in Health, 2011
- Racial/Ethnic Disparities in Access to Care and Survival for Patients With Early-Stage Hepatocellular CarcinomaArchives of Surgery, 2010
- Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United StatesCancer, 2010
- Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005Journal of Clinical Oncology, 2009
- Epidemiology of Hepatocellular Carcinoma in Hispanics in the United StatesArchives of internal medicine (1960), 2007
- The Epidemiology of ObesityGastroenterology, 2007